Zika Virus — What Clinicians Need to Know

Zika virus is a mosquito-borne flavivirus transmitted primarily by Aedes aegypti mosquitoes and an estimated 80% of persons infected with Zika virus are asymptomatic. Symptomatic disease is generally mild, with symptoms of fever, maculopapular rash, arthralgia, or nonpurulent conjunctivitis that typically last from several days to one week. Sporadic cases and outbreaks of Zika virus disease have occurred in countries in Africa and Southeast Asia. In 2015, the first local Zika virus transmission in the Americas was reported in Brazil and local transmission has now been in several countries or territories in the Americas. In the current outbreak in Brazil, a marked increase in the number of infants born with microcephaly has been reported and Zika virus infections have been confirmed in some infants with microcephaly. However, it is not known how many of the microcephaly cases are associated with Zika virus infection. Travelers to areas with ongoing outbreaks are at risk of becoming infected and spreading the virus to new areas, including the continental United States. During this Clinician Outreach and Communication Activity (COCA) Call, participants will learn about the epidemiology and clinical manifestation of Zika virus disease and how early recognition and reporting of suspected cases can mitigate the risk of local transmission.

 

 
Resource Type(s)
Presentation
Topic(s)
Birth Defects
Chikungunya
Clinical Guidelines
Counseling
Dengue
Diagnostics
Guillain-Barre Syndrome
Microcephaly
Mosquito Control
Mosquito Transmission
Pregnancy
Prevention
Sexual Transmission
Signs and Symptoms
Surveillance
Travel
Treatment
Audience(s)
Health Care Workers
Language(s)
English
Spanish
Country(ies)
Global
Source(s)
Centers for Disease Control and Prevention

Add new comment

Your email address will not be published. Required fields are marked *